Results 151 to 160 of about 16,378 (224)

The impact of relapse on patient disability, clinical outcomes, and subsequent burdens to patients with neuromyelitis optica spectrum disorder and caregivers. [PDF]

Mult Scler J Exp Transl Clin
Huda S, Kleman M, Myren KJ, Unsworth M, Castellano G, Taskopru BK, Fitzmaurice K.   +6 more
europepmc   +1 more source

Clinical features of three cases of neurosarcoidosis with a positive aquaporin-4 antibody requiring differentiation from neuromyelitis optica spectrum disorder

Kazuki Yamada, Satoshi Nunomura, Takashi Inoue, S. N. Nakamura, Kazuhiro Horiuchi, Ichiro Yabe   +5 more
openalex   +2 more sources

Neuromyelitis Optica Spectrum Disorder Associated with Cervical Spondylosis

Chinese Medical Journal, 2015
Yuan Zhou, Lin Zhu, Hui-Lin Cheng, Yi-Xing Lin   +3 more
doaj   +1 more source

The pathologic and diagnostic in magnetic resonance imaging of brain and cervical spine of patients with neuromyelitis optica spectrum disorder.

, 2018
Roshanak Mehdipour-Dastjerdi, Fereshteh Ashtari, Vahid Shaygannejad, Marjan Mansourian, Ali Safaei   +4 more
openalex   +1 more source

Real-world effectiveness and safety of eculizumab in AQP4-IgG-positive neuromyelitis optica spectrum disorder. [PDF]

J Neurol
Koc ER, Yetkin MF, Saridas F, Turan OF, Sevim S, Terzi M, Sen S, Tutuncu M, Uygunoglu U, Kurtuncu M, Gunduz T, Tepe N, Canbaz-Kabay S, Efendi H, Bunul SD, Cetinkaya-Tezer D, Gungor-Dogan İ, Demir S, Altunrende B, Kale-Icen N, Omerhoca S, Kamisli O, Demir CF, Karakurum-Yuksel B, Uzunkopru C, Beckmann Y, Cilingir V, Agan K, Gumus H, Ercan M, Kocer B, Gluscevic S, Carnero-Contentti E, Casallas-Vanegas A, Camera V, Calabrese M, Ozkaya G, Akman-Demir G, Boz C, Altıntas A, Siva A.   +40 more
europepmc   +1 more source

Transitioning to a C5 inhibitor for aquaporin-4 antibody–positive neuromyelitis optica spectrum disorder intolerant of anti-CD19 therapy: a case report

Amanda Piquet, Mallory Lowe, Jeffrey Bennett   +2 more
openalex   +1 more source

Complexity and wide range of neuromyelitis optica spectrum disorders: more than typical manifestations

, 2017
Jinming Han, Mengge Yang, Jie Zhu, Tao Jin   +3 more
openalex   +2 more sources

Relapse-related outcomes in the Danish population-based AQP4- antibody seropositive neuromyelitis optica spectrum disorder cohort. [PDF]

Neurol Sci
Mamoei S, Möller S, Magyari M, Sellebjerg F, Frederiksen JL, Svendsen KB, Saleem R, Søndergaard HB, Nilsson AC, Papp V, Illes Z.   +10 more
europepmc   +1 more source

Subacute myelopathy: Think beyond neuromyelitis optica spectrum disorder

Annals of Indian Academy of Neurology, 2019
Ananthanarayanan Kasinathan, Renu Suthar, Sameer Vyas, Arushi Gahlot Saini, Naveen Sankhyan, Savita Attri   +5 more
doaj   +1 more source

Switching from Rituximab to Eculizumab in US Patients with Neuromyelitis Optica Spectrum Disorder: Impact on Hospitalizations. [PDF]

Neurol Ther
Lee J, Kielhorn A, Fam S, Riser E, Flanagan EP.   +4 more
europepmc   +1 more source